Skip to main content
SpringerLink
Log in

Acute Exacerbations of Airway Inflammation

  • Reference work entry
  • First Online:
Book cover Compendium of Inflammatory Diseases

  • 206 Accesses

Support

Dr. Goyal is supported by a project grant from the Australian National Health and Medical Research Council (NHMRC) project grant (number 1019834) and the NHMRC Centre for Research Excellence in Lung Health of Aboriginal and Torres Strait Islander Children (grant number 1040830). Prof. Chang is supported by the NHMRC practitioner fellowship (grant 545216). The views expressed in this publication are those of the authors and do not reflect the views of the NHMRC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aaron, S. D., Donaldson, G. C., Whitmore, G. A., Hurst, J. R., Ramsay, T., & Wedzicha, J. A. (2012). Time course and pattern of COPD exacerbation onset. Thorax, 67(3), 238–243. doi:10.1136/thoraxjnl-2011-200768.

    Article  PubMed  Google Scholar 

  • Aaron, S. D., Vandemheen, K. L., Maltais, F., Field, S. K., Sin, D. D., Bourbeau, J., et al. (2013). TNFα antagonists for acute exacerbations of COPD: A randomised double-blind controlled trial. Thorax, 68(2), 142–148. doi:10.1136/thoraxjnl-2012-202432.

    Google Scholar 

  • Advani, S., Sengupta, A., Forman, M., Valsamakis, A., & Milstone, A. M. (2012). Detecting respiratory viruses in asymptomatic children. Pediatric Infectious Disease Journal, 31(12), 1221–1226. doi:10.1097/INF.0b013e318265a804.

    Article  PubMed  PubMed Central  Google Scholar 

  • Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., et al. (2011). Azithromycin for prevention of exacerbations of COPD. New England Journal of Medicine, 365(8), 689–698. doi:10.1056/NEJMoa1104623.

    Google Scholar 

  • Anzueto, A., & Niederman, M. S. (2003). Diagnosis and treatment of rhinovirus respiratory infections. CHEST Journal, 123(5), 1664–1672. doi:10.1378/chest.123.5.1664.

    Article  CAS  Google Scholar 

  • Arden, K. E., Chang, A. B., Lambert, S. B., Nissen, M. D., Sloots, T. P., & Mackay, I. M. (2010). Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. Journal of Medical Virology, 82(8), 1458–1461. doi:10.1002/jmv.21819.

    Article  PubMed  Google Scholar 

  • Bach, P. B., Brown, C., Gelfand, S. E., McCrory, D. C., American College of Physicians-American Society of Internal Medicine, & American College of Chest Physicians. (2001). Management of acute exacerbations of chronic obstructive pulmonary disease: A summary and appraisal of published evidence. Annals of Internal Medicine, 134(7), 600–620.

    Article  CAS  PubMed  Google Scholar 

  • Baines, K. J., Simpson, J. L., Wood, L. G., Scott, R. J., & Gibson, P. G. (2011). Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. The Journal of Allergy and Clinical Immunology, 127(1), 153–160, 160 e151–159. doi: 10.1016/j.jaci.2010.10.024.

    Google Scholar 

  • Bains, S. N., & Judson, M. A. (2012). Allergic bronchopulmonary aspergillosis. Clinics in Chest Medicine, 33(2), 265–281. doi:10.1016/j.ccm.2012.02.003.

    Article  PubMed  Google Scholar 

  • Barnig, C., & Casset, A. (2012). Respiratory allergens and asthma exacerbation. Revue des Maladies Respiratoires, 29(6), 810–819. doi:10.1016/j.rmr.2012.04.004.

    Article  CAS  PubMed  Google Scholar 

  • Bhogal, S. K., McGillivray, D., Bourbeau, J., Benedetti, A., Bartlett, S., & Ducharme, F. M. (2012). Early administration of systemic corticosteroids reduces hospital admission rates for children with moderate and severe asthma exacerbation. Annals of Emergency Medicine, 60(1), 84–91 e83. doi:10.1016/j.annemergmed.2011.12.027.

    Article  PubMed  Google Scholar 

  • Bischoff, E. W., Hamd, D. H., Sedeno, M., Benedetti, A., Schermer, T. R., Bernard, S., et al. (2011). Effects of written action plan adherence on COPD exacerbation recovery. Thorax, 66(1), 26–31. doi:10.1136/thx.2009.127621.

    Google Scholar 

  • Black, P. N., Morgan-Day, A., McMillan, T. E., Poole, P. J., & Young, R. P. (2004). Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulmonary Medicine, 4, 13. doi:10.1186/1471-2466-4-13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Brusselle, G. G., Vanderstichele, C., Jordens, P., Deman, R., Slabbynck, H., Ringoet, V., et al. (2013). Azithromycin for prevention of exacerbations in severe asthma (AZISAST): A multicentre randomised double-blind placebo-controlled trial. Thorax. doi:10.1136/thoraxjnl-2012-202698.

    Google Scholar 

  • Burness, C. B., & Keating, G. M. (2012). Mannitol dry powder for inhalation: In patients with cystic fibrosis. Drugs, 72(10), 1411–1421. doi:10.2165/11208950-000000000-00000.

    Article  CAS  PubMed  Google Scholar 

  • Busse, W. W., Lemanske, R. F., Jr., & Gern, J. E. (2010). Role of viral respiratory infections in asthma and asthma exacerbations. The Lancet, 376(9743), 826–834. doi:10.1016/S0140-6736(10)61380-3.

    Article  Google Scholar 

  • Chang, A. B. (2011). Bronchiectasis: So much yet to learn and to do. Paediatric Respiratory Reviews, 12(2), 89–90. doi:10.1016/j.prrv.2011.01.001.

    Article  CAS  PubMed  Google Scholar 

  • Chang, A. B., & Bilton, D. (2008). Exacerbations in cystic fibrosis: 4 · Non-cystic fibrosis bronchiectasis. Thorax, 63(3), 269–276. doi:10.1136/thx.2006.060913.

    Article  CAS  PubMed  Google Scholar 

  • Chang, A. B., Redding, G. J., & Everard, M. L. (2008). Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatric Pulmonology, 43(6), 519–531. doi:10.1002/ppul.20821.

    Article  CAS  PubMed  Google Scholar 

  • Chang, A. B., Bell, S. C., Byrnes, C. A., Grimwood, K., Holmes, P. W., King, P. T., et al. (2010). Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. The Medical Journal of Australia, 193(6), 356–365.

    Google Scholar 

  • Chang, A. B., Marsh, R. L., Smith-Vaughan, H. C., & Hoffman, L. R. (2012). Emerging drugs for bronchiectasis. Expert Opinion on Emerging Drugs, 17(3), 361–378. doi:10.1517/14728214.2012.702755.

    Article  CAS  PubMed  Google Scholar 

  • Chen, A. H., Chen, R. C., Zhan, J. Y., Huang, S., Lin, Y. N., Chen, D. H., et al. (2012). The efficacy of nebulized budesonide in acute moderate to severe exacerbations of asthma in children. Zhonghua Jie He He Hu Xi Za Zhi, 35(4), 269–274.

    Google Scholar 

  • Chesnutt, M. S. (1998). Management of asthma exacerbations. Clinical Cornerstone, 1(2), 39–56. doi:10.1016/S1098-3597(98)80005-7.

    Article  CAS  PubMed  Google Scholar 

  • Chew, K. S., Kamarudin, H., & Hashim, C. W. (2012). A randomized open-label trial on the use of budesonide/formoterol (Symbicort(R)) as an alternative reliever medication for mild to moderate asthmatic attacks. International Journal of Emergency Medicine, 5, 16. doi:10.1186/1865-1380-5-16.

    Article  PubMed  PubMed Central  Google Scholar 

  • Cole, P. J. (1986). Inflammation: A two-edged sword – The model of bronchiectasis. European Journal of Respiratory Diseases. Supplement, 147, 6–15.

    CAS  PubMed  Google Scholar 

  • Craig, A., Mai, J., Cai, S., & Jeyaseelan, S. (2009). Neutrophil recruitment to the lungs during bacterial pneumonia. Infection and Immunity, 77(2), 568–575. doi:10.1128/iai.00832-08.

    Article  CAS  PubMed  Google Scholar 

  • Crockett, A. J., Cranston, J. M., Latimer, K. M., & Alpers, J. H. (2001). Mucolytics for bronchiectasis. Cochrane Database of Systematic Reviews, 1, CD001289. doi:10.1002/14651858.cd001289.

    Google Scholar 

  • Davies, J. C., & Alton, E. W. (2009). Monitoring respiratory disease severity in cystic fibrosis. Respiratory Care, 54(5), 606–617.

    Article  PubMed  Google Scholar 

  • Daviskas, E., Anderson, S. D., Gomes, K., Briffa, P., Cochrane, B., Chan, H. K., et al. (2005). Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputum. Respirology, 10(1), 46–56. doi:10.1111/j.1440-1843.2005.00659.x.

    Google Scholar 

  • Daviskas, E., Anderson, S. D., & Young, I. H. (2010). Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis. Respiratory Medicine, 104(3), 371–377. doi:10.1016/j.rmed.2009.10.021.

    Article  PubMed  Google Scholar 

  • de Almeida, M. B., Zerbinati, R. M., Tateno, A. F., Oliveira, C. M., Romao, R. M., Rodrigues, J. C., et al. (2010). Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerging Infectious Diseases, 16(6), 996–999. doi:10.3201/eid1606.100063.

    Google Scholar 

  • Dickens, J. A., Miller, B. E., Edwards, L. D., Silverman, E. K., Lomas, D. A., Tal-Singer, R., et al. (2011). COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respiratory Research, 12, 146. doi:10.1186/1465-9921-12-146.

    Google Scholar 

  • Didierlaurent, A., Goulding, J., Patel, S., Snelgrove, R., Low, L., Bebien, M., et al. (2008). Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. The Journal of Experimental Medicine, 205(2), 323–329. doi:10.1084/jem.20070891.

    Google Scholar 

  • Donaldson, S. H., Bennett, W. D., Zeman, K. L., Knowles, M. R., Tarran, R., & Boucher, R. C. (2006). Mucus clearance and lung function in cystic fibrosis with hypertonic saline. The New England Journal of Medicine, 354(3), 241–250. doi:10.1056/NEJMoa043891.

    Article  CAS  PubMed  Google Scholar 

  • D’Silva, L., Hassan, N., Wang, H. Y., Kjarsgaard, M., Efthimiadis, A., Hargreave, F. E., et al. (2011). Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Canadian Respiratory Journal, 18(3), 144–148.

    Google Scholar 

  • Duffy, N., Walker, P., Diamantea, F., Calverley, P. M., & Davies, L. (2005). Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial. Thorax, 60(9), 713–717. doi:10.1136/thx.2004.036046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eastham, K. M., Fall, A. J., Mitchell, L., & Spencer, D. A. (2004). The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax, 59(4), 324–327. doi:10.1136/thx.2003.011577.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Edwards, L., Shirtcliffe, P., Wadsworth, K., Healy, B., Jefferies, S., Weatherall, M., et al. (2013). Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: A randomised double-blind placebo-controlled trial. Thorax. doi:10.1136/thoraxjnl-2012-202225.

    Google Scholar 

  • Effing, T. (2012). Action plans and case manager support may hasten recovery of symptoms following an acute exacerbation in patients with chronic obstructive pulmonary disease (COPD). Journal of Physiotherapy, 58(1), 60. doi:10.1016/s1836-9553(12)70076-0.

    Article  PubMed  Google Scholar 

  • Elborn, J. S., Perrett, J., Forsman-Semb, K., Marks-Konczalik, J., Gunawardena, K., & Entwistle, N. (2012). Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis. The European Respiratory Journal, 40(4), 969–976. doi:10.1183/09031936.00194611.

    Article  CAS  PubMed  Google Scholar 

  • Ferkol, T., Rosenfeld, M., & Milla, C. E. (2006). Cystic fibrosis pulmonary exacerbations. The Journal of Pediatrics, 148(2), 259–264. doi:10.1016/j.jpeds.2005.10.019.

    Article  PubMed  Google Scholar 

  • Findley, L. J., & Sahn, S. A. (1981). The value of chest roentgenograms in acute asthma in adults. Chest, 80(5), 535–536.

    Article  CAS  PubMed  Google Scholar 

  • Fireman, P. (2003). Understanding asthma pathophysiology. Allergy and Asthma Proceedings: The Official Journal of Regional and State Allergy Societies, 24(2), 79–83.

    CAS  Google Scholar 

  • Flor-Escriche, X., Rodriguez-Mas, M., Espiau, M., Castan-Ensenat, X., Vigata-Reig, J. M., Poblet-Cortes, R., et al. (2011). Compliance with guidelines in the treatment of asthma exacerbations in primary care. Therapeutic Advances in Respiratory Disease, 5(6), 369–375. doi:10.1177/1753465811416698.

    Google Scholar 

  • Friege, B., Friege, L., Pelz, J., Weber, M., von Spiegel, T., & Schroder, S. (2009). Bronchial asthma and chronic obstructive pulmonary disease with acute exacerbation: Preclinical differential diagnostic and emergency treatment. Anaesthesist, 58(6), 611–622. doi:10.1007/s00101-009-1536-x.

    Article  CAS  PubMed  Google Scholar 

  • From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2012. Available from: http://www.ginasthma.org/. 2012.

  • Gandia, F., Guenard, H., Sriha, B., Tabka, Z., & Rouatbi, S. (2012). Inhaled magnesium sulphate in the treatment of bronchial hyperresponsiveness. Magnesium Research. doi:10.1684/mrh.2012.0323.

    PubMed  Google Scholar 

  • Garcha, D. S., Thurston, S. J., Patel, A. R. C., Mackay, A. J., Goldring, J. J. P., Donaldson, G. C., et al. (2012). Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax, 67(12), 1075–1080. doi:10.1136/thoraxjnl-2012-201924.

    Google Scholar 

  • Gent, J. F., Belanger, K., Triche, E. W., Bracken, M. B., Beckett, W. S., & Leaderer, B. P. (2009). Association of pediatric asthma severity with exposure to common household dust allergens. Environmental Research, 109(6), 768–774. doi:10.1016/j.envres.2009.04.010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gentile, N. T., Ufberg, J., Barnum, M., McHugh, M., & Karras, D. (2003). Guidelines reduce x-ray and blood gas utilization in acute asthma. The American Journal of Emergency Medicine, 21(6), 451–453.

    Article  PubMed  Google Scholar 

  • Gjoerup, J., Hilberg, O., & Bendstrup, E. (2012). Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults. Respirology, 17(6), 927–932. doi:10.1111/j.1440-1843.2012.02189.x.

    Article  PubMed  Google Scholar 

  • Goeminne, P., & Dupont, L. (2010). Non-cystic fibrosis bronchiectasis: Diagnosis and management in 21st century. Postgraduate Medical Journal, 86(1018), 493–501. doi:10.1136/pgmj.2009.091041.

    Article  PubMed  Google Scholar 

  • Goss, C. H., & Burns, J. L. (2007). Exacerbations in cystic fibrosis · 1: Epidemiology and pathogenesis. Thorax, 62(4), 360–367. doi:10.1136/thx.2006.060889.

    Article  PubMed  PubMed Central  Google Scholar 

  • Gowers, A. M., Cullinan, P., Ayres, J. G., Anderson, H. R., Strachan, D. P., Holgate, S. T., et al. (2012). Does outdoor air pollution induce new cases of asthma? Biological plausibility and evidence; a review. Respirology, 17(6), 887–898. doi:10.1111/j.1440-1843.2012.02195.x.

    Google Scholar 

  • Graham, V., Lasserson, T., & Rowe, B. H. (2001). Antibiotics for acute asthma. Cochrane Database of Systematic Reviews, 3, CD002741. doi:10.1002/14651858.cd002741.

    Google Scholar 

  • Group, C. I. A. S. (1994). In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. Chest, 105(5), 1411–1419.

    Article  Google Scholar 

  • Gupta, S., Siddiqui, S., Haldar, P., Raj, J. V., Entwisle, J. J., Wardlaw, A. J., et al. (2009). Qualitative analysis of high-resolution CT scans in severe asthma. Chest, 136(6), 1521–1528. doi:10.1378/chest.09-0174.

    Google Scholar 

  • Guran, T., Ersu, R., Karadag, B., Nuri Akpinar, I., Yanikkaya Demirel, G., Hekim, N., et al. (2007). Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis. Pediatric Pulmonology, 42(4), 362–369. doi:10.1002/ppul.20587.

    Article  PubMed  Google Scholar 

  • Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., & Mannino, D. M. (2006). Global burden of COPD: Systematic review and meta-analysis. The European Respiratory Journal, 28(3), 523–532. doi:10.1183/09031936.06.00124605.

    Article  CAS  PubMed  Google Scholar 

  • Hargreave, F. E. (2007). Quantitative sputum cell counts as a marker of airway inflammation in clinical practice. Current Opinion in Allergy and Clinical Immunology, 7(1), 102–106. doi:10.1097/ACI.0b013e328013e3c2.

    Article  PubMed  Google Scholar 

  • Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., et al. (2010). Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 363(12), 1128–1138. doi:10.1056/NEJMoa0909883.

    Google Scholar 

  • Indinnimeo, L., Tancredi, G., Barreto, M., De Castro, G., Zicari, A. M., Monaco, F., et al. (2007). Effects of a program of hospital-supervised chest physical therapy on lung function tests in children with chronic respiratory disease: 1-year follow-up. International Journal of Immunopathology and Pharmacology, 20(4), 841–845.

    Google Scholar 

  • Jat, K. R., & Chawla, D. (2012). Ketamine for management of acute exacerbations of asthma in children. Cochrane Database of Systematic Reviews, 11, CD009293. doi:10.1002/14651858.CD009293.pub2.

    PubMed  Google Scholar 

  • Kapur, N., Masters, I. B., & Chang, A. B. (2009). Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations. Respiratory Medicine, 103(11), 1681–1687. doi:10.1016/j.rmed.2009.05.007.

    Article  PubMed  Google Scholar 

  • Kapur, N., Masters, I. B., & Chang, A. B. (2010). Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis what influences lung function stability? CHEST Journal, 138(1), 158–164. doi:10.1378/chest.09-2932.

    Article  Google Scholar 

  • Kapur, N., Masters, I. B., Morris, P. S., Galligan, J., Ware, R., & Chang, A. B. (2012). Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis. Pediatric Pulmonology, 47(1), 68–75. doi:10.1002/ppul.21518.

    Article  PubMed  Google Scholar 

  • Kelleher, D. L., Mehta, R. S., Jean-Francois, B. M., Preece, A. F., Blowers, J., Crater, G. D., et al. (2012). Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: A randomized crossover trial. PloS One, 7(12), e50716. doi:10.1371/journal.pone.0050716.

    Google Scholar 

  • Kellett, F., & Robert, N. M. (2011). Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respiratory Medicine, 105(12), 1831–1835. doi:10.1016/j.rmed.2011.07.019.

    Article  PubMed  Google Scholar 

  • Kellett, F., Redfern, J., & Niven, R. M. (2005). Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respiratory Medicine, 99(1), 27–31.

    Article  CAS  PubMed  Google Scholar 

  • Ko, F. W. S., & Hui, D. S. C. (2012). Air pollution and chronic obstructive pulmonary disease. Respirology, 17(3), 395–401. doi:10.1111/j.1440-1843.2011.02112.x.

    Article  PubMed  Google Scholar 

  • Koziol-White, C. J., & Panettieri, R. A., Jr. (2011). Airway smooth muscle and immunomodulation in acute exacerbations of airway disease. Immunological Reviews, 242(1), 178–185. doi:10.1111/j.1600-065X.2011.01022.x.

    Article  CAS  PubMed  Google Scholar 

  • Langley, S. J., Goldthorpe, S., Craven, M., Woodcock, A., & Custovic, A. (2005). Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects. Thorax, 60(1), 17–21. doi:10.1136/thx.2004.027839.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lasserson, T., Holt, K., Evans, D., & Greenstone, M. (2001). Anticholinergic therapy for bronchiectasis. Cochrane Database of Systematic Reviews, 4, CD002163. doi:10.1002/14651858.cd002163.

    Google Scholar 

  • Mallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., et al. (2011). Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. American Journal of Respiratory and Critical Care Medicine, 183(6), 734–742. doi:10.1164/rccm.201006-0833OC.

    Google Scholar 

  • Mallia, P., Footitt, J., Sotero, R., Jepson, A., Contoli, M., Trujillo-Torralbo, M. B., et al. (2012). Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 186(11), 1117–1124. doi:10.1164/rccm.201205-0806OC.

    Google Scholar 

  • Marchant, J. M., Masters, I. B., Taylor, S. M., Cox, N. C., Seymour, G. J., & Chang, A. B. (2006). Evaluation and outcome of young children with chronic cough. CHEST Journal, 129(5), 1132–1141. doi:10.1378/chest.129.5.1132.

    Article  Google Scholar 

  • Marchant, J. M., Gibson, P. G., Grissell, T. V., Timmins, N. L., Masters, I. B., & Chang, A. B. (2008). Prospective assessment of protracted bacterial bronchitis: Airway inflammation and innate immune activation. Pediatric Pulmonology, 43(11), 1092–1099. doi:10.1002/ppul.20906.

    Article  PubMed  Google Scholar 

  • Marchant, J., Masters, I. B., Champion, A., Petsky, H., & Chang, A. B. (2012). Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough. Thorax, 67(8), 689–693. doi:10.1136/thoraxjnl-2011-201506.

    Article  PubMed  Google Scholar 

  • Masoli, M., Fabian, D., Holt, S., & Beasley, R. (2004). The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy, 59(5), 469–478.

    Article  PubMed  Google Scholar 

  • Mathew, S., Zeitlin, D., & Rickett, K. (2012). Clinical Inquiry: Do antibiotics improve outcomes for patients hospitalized with COPD exacerbations? The Journal of Family Practice, 61(9), 561–573.

    PubMed  Google Scholar 

  • McDonald, V. M., & Gibson, P. G. (2012). Exacerbations of severe asthma. Clinical and Experimental Allergy, 42(5), 670–677. doi:10.1111/j.1365-2222.2012.03981.x.

    Article  CAS  PubMed  Google Scholar 

  • McGarvey, J. M., & Pollack, C. V. (2008). Heliox in airway management. Emergency Medicine Clinics of North America, 26(4), 905–920. doi:10.1016/j.emc.2008.07.007. viii.

    Article  PubMed  Google Scholar 

  • Metersky, M. L., & O’Donnell, A. E. (2012). Preface. Bronchiectasis. Clinics in Chest Medicine, 33(2), xi–xii. doi:10.1016/j.ccm.2012.04.002.

    Article  PubMed  Google Scholar 

  • Meyer, K. C. (2007). Bronchoalveolar lavage as a diagnostic tool. Seminars in Respiratory and Critical Care Medicine, 28(5), 546–560. doi:10.1055/s-2007-991527.

    Article  PubMed  Google Scholar 

  • Meyer, K. C., Raghu, G., Baughman, R. P., Brown, K. K., Costabel, U., du Bois, R. M., et al. (2012). An official American Thoracic Society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. American Journal of Respiratory and Critical Care Medicine, 185(9), 1004–1014. doi:10.1164/rccm.201202-0320ST.

    Google Scholar 

  • Mitra, A., Bassler, D., Goodman, K., Lasserson, T. J., & Ducharme, F. M. (2005). Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database of Systematic Reviews, 2, CD001276. doi:10.1002/14651858.CD001276.pub2.

    Google Scholar 

  • Mortensen, J., Hansen, A., Falk, M., Nielsen, I. K., & Groth, S. (1993). Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest, 103(3), 805–811.

    Article  CAS  PubMed  Google Scholar 

  • Murray, M. P., Pentland, J. L., & Hill, A. T. (2009a). A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. European Respiratory Journal, 34(5), 1086–1092. doi:10.1183/09031936.00055509.

    Article  CAS  PubMed  Google Scholar 

  • Murray, M. P., Turnbull, K., MacQuarrie, S., & Hill, A. T. (2009b). Assessing response to treatment of exacerbations of bronchiectasis in adults. European Respiratory Journal, 33(2), 312–318. doi:10.1183/09031936.00122508.

    Article  CAS  PubMed  Google Scholar 

  • Nair, P., & Hargreave, F. E. (2010). Measuring bronchitis in airway diseases: Clinical implementation and application: Airway hyperresponsiveness in asthma: Its measurement and clinical significance. Chest, 138(2 Suppl), 38S–43S. doi:10.1378/chest.10-0094.

    Article  PubMed  Google Scholar 

  • Nair, G. B., & Ilowite, J. S. (2012). Pharmacologic agents for mucus clearance in bronchiectasis. Clinics in Chest Medicine, 33(2), 363–370. doi:10.1016/j.ccm.2012.02.008.

    Article  PubMed  Google Scholar 

  • O’Byrne, P. M., Pedersen, S., Lamm, C. J., Tan, W. C., Busse, W. W., & Group, o. b. o. t. S. I. (2009). Severe exacerbations and decline in lung function in asthma. American Journal of Respiratory and Critical Care Medicine, 179(1), 19–24. doi:10.1164/rccm.200807-1126OC.

    Article  PubMed  Google Scholar 

  • O’Donnell, D. E. (2006). Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society, 3(2), 180–184. doi:10.1513/pats.200508-093DO.

    Article  PubMed  Google Scholar 

  • Patel, I. S., Vlahos, I., Wilkinson, T. M., Lloyd-Owen, S. J., Donaldson, G. C., Wilks, M., et al. (2004). Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 170(4), 400–407. doi:10.1164/rccm.200305-648OC.

    Google Scholar 

  • Patick, A. K. (2006). Rhinovirus chemotherapy. Antiviral Research, 71(2–3), 391–396. doi:10.1016/j.antiviral.2006.03.011.

    Article  CAS  PubMed  Google Scholar 

  • Pizzutto, S. J., Grimwood, K., Bauert, P., Schutz, K. L., Yerkovich, S. T., Upham, J. W., et al. (2013). Bronchoscopy contributes to the clinical management of indigenous children newly diagnosed with bronchiectasis. Pediatric Pulmonology, 48(1), 67–73. doi:10.1002/ppul.22544.

    Article  PubMed  Google Scholar 

  • Powell, C., Dwan, K., Milan, S. J., Beasley, R., Hughes, R., Knopp-Sihota, J. A., et al. (2012). Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database of Systematic Reviews, 12, CD003898. doi:10.1002/14651858.CD003898.pub5.

    PubMed  Google Scholar 

  • Puderbach, M., & Eichinger, M. (2010). The role of advanced imaging techniques in cystic fibrosis follow-up: Is there a place for MRI? Pediatric Radiology, 40(6), 844–849. doi:10.1007/s00247-010-1589-7.

    Article  PubMed  Google Scholar 

  • Quint, J. K., Donaldson, G. C., Goldring, J. J. P., Baghai-Ravary, R., Hurst, J. R., & Wedzicha, J. A. (2010). Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. CHEST Journal, 137(4), 812–822. doi:10.1378/chest.09-1541.

    Article  CAS  Google Scholar 

  • Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., et al. (2009). An Official American Thoracic Society/European Respiratory Society statement: Asthma control and exacerbations: Standardizing endpoints for clinical asthma trials and clinical practice. American Journal of Respiratory and Critical Care Medicine, 180(1), 59–99. doi:10.1164/rccm.200801-060ST.

    Google Scholar 

  • Restrepo, R. D. (2007). Inhaled adrenergics and anticholinergics in obstructive lung disease: Do they enhance mucociliary clearance? Respiratory Care, 52(9), 1159–1173. discussion 1173–1155.

    PubMed  Google Scholar 

  • Ristovski, Z. D., Miljevic, B., Surawski, N. C., Morawska, L., Fong, K. M., Goh, F., et al. (2012). Respiratory health effects of diesel particulate matter. Respirology, 17(2), 201–212. doi:10.1111/j.1440-1843.2011.02109.x.

    Article  PubMed  Google Scholar 

  • Robroeks, C. M., van Vliet, D., Jobsis, Q., Braekers, R., Rijkers, G. T., Wodzig, W. K., et al. (2012). Prediction of asthma exacerbations in children: Results of a one-year prospective study. Clinical and Experimental Allergy, 42(5), 792–798. doi:10.1111/j.1365-2222.2012.03992.x.

    Google Scholar 

  • Rogers, D. F. (2007). Mucoactive agents for airway mucus hypersecretory diseases. Respiratory Care, 52(9), 1176–1197.

    PubMed  Google Scholar 

  • Rubin, B. K. (2002). The pharmacologic approach to airway clearance: Mucoactive agents. Respiratory Care, 47(7), 818–822.

    PubMed  Google Scholar 

  • Santus, P., Russo, A., Madonini, E., Allegra, L., Blasi, F., Centanni, S., et al. (2012). How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan. Respiratory Research, 13, 95. doi:10.1186/1465-9921-13-95.

    Google Scholar 

  • Sherman, S., Skoney, J. A., & Ravikrishnan, K. P. (1989). Routine chest radiographs in exacerbations of chronic obstructive pulmonary disease. Diagnostic value. Archives of Internal Medicine, 149(11), 2493–2496.

    Article  CAS  PubMed  Google Scholar 

  • Silverman, R. A., Foley, F., Dalipi, R., Kline, M., & Lesser, M. (2012). The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to bronchodilators: A pilot study. Respiratory Medicine, 106(8), 1096–1102.

    Article  PubMed  Google Scholar 

  • Simpson, B. M., Custovic, A., Simpson, A., Hallam, C. L., Walsh, D., Marolia, H., et al. (2001). NAC Manchester Asthma and Allergy Study (NACMAAS): Risk factors for asthma and allergic disorders in adults. Clinical and Experimental Allergy, 31(3), 391–399.

    Google Scholar 

  • Simpson, J. L., Phipps, S., & Gibson, P. G. (2009). Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacology and Therapeutics, 124(1), 86–95. doi:10.1016/j.pharmthera.2009.06.004.

    Article  CAS  PubMed  Google Scholar 

  • Snow, V., Lascher, S., Mottur-Pilson, C., Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest, P., & The American College of Physicians-American Society of Internal, M. (2001). Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine, 134(7), 595–599.

    Article  CAS  PubMed  Google Scholar 

  • Song, W. J., & Chang, Y. S. (2012). Magnesium sulfate for acute asthma in adults: A systematic literature review. Asia Pacific Allergy, 2(1), 76–85. doi:10.5415/apallergy.2012.2.1.76.

    Article  PubMed  PubMed Central  Google Scholar 

  • Southern, K. W., Barker, P. M., Solis-Moya, A., & Patel, L. (2012). Macrolide antibiotics for cystic fibrosis. Cochrane Database of Systematic Reviews, 11, CD002203. doi:10.1002/14651858.CD002203.pub4.

    PubMed  Google Scholar 

  • Staggs, L., Peek, M., Southard, G., Gracely, E., Baxendale, S., Cross, K. P., et al. (2012). Evaluating the length of stay and value of time in a pediatric emergency department with two models by comparing two different albuterol delivery systems. Journal of Medical Economics, 15(4), 704–711. doi:10.3111/13696998.2012.674587.

    Article  PubMed  Google Scholar 

  • Stenbit, A. E., & Flume, P. A. (2011). Pulmonary exacerbations in cystic fibrosis. Current Opinion in Pulmonary Medicine, 17(6), 442–447. doi:10.1097/MCP.0b013e32834b8c04.

    PubMed  Google Scholar 

  • Stevens, D. A., Schwartz, H. J., Lee, J. Y., Moskovitz, B. L., et al. (2000). A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. The New England Journal of Medicine, 342(11), 756–762.

    Article  CAS  PubMed  Google Scholar 

  • Strek, M. E. (2012). Improving asthma management written asthma action plan time for an action plan. CHEST Journal, 142(5), 1085–1087. doi:10.1378/chest.12-1115.

    Article  Google Scholar 

  • Sullivan, S. D., Ramsey, S. D., & Lee, T. A. (2000). The economic burden of COPD. Chest, 117(2 Suppl), 5S–9S.

    Article  CAS  PubMed  Google Scholar 

  • Teoh, L., Cates, C. J., Hurwitz, M., Acworth, J. P., van Asperen, P., & Chang, A. B. (2012). Anticholinergic therapy for acute asthma in children. Cochrane Database of Systematic Reviews, 4, CD003797. doi:10.1002/14651858.CD003797.pub2.

    Google Scholar 

  • The air quality health index and asthma morbidity: A population-based study. (2013). Environ Health Perspect, 121(1), 46–52. doi:10.1289/ehp.1104816.

    Google Scholar 

  • Thomas, R. A., Green, R. H., Brightling, C. E., Birring, S. S., Parker, D., Wardlaw, A. J., et al. (2004). The influence of age on induced sputum differential cell counts in normal subjects. Chest, 126(6), 1811–1814. doi:10.1378/chest.126.6.1811.

    Article  PubMed  Google Scholar 

  • Trappenburg, J. C., Monninkhof, E. M., Bourbeau, J., Troosters, T., Schrijvers, A. J., Verheij, T. J., et al. (2011). Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: A multicentre randomised controlled trial. Thorax, 66(11), 977–984. doi:10.1136/thoraxjnl-2011-200071.

    Article  PubMed  Google Scholar 

  • van der Valk, R. J., Baraldi, E., Stern, G., Frey, U., & de Jongste, J. C. (2012). Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy, 67(2), 265–271. doi:10.1111/j.1398-9995.2011.02734.x.

    Article  PubMed  CAS  Google Scholar 

  • Vogelmeier, C., Aquino, T. O., O’Brien, C. D., Perrett, J., & Gunawardena, K. A. (2012). A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium. COPD, 9(2), 111–120. doi:10.3109/15412555.2011.641803.

    Article  PubMed  Google Scholar 

  • Vollenweider, D. J., Jarrett, H., Steurer-Stey, C. A., Garcia-Aymerich, J., & Puhan, M. A. (2012). Antibiotics for exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 12, CD010257. doi:10.1002/14651858.cd010257.

    PubMed  Google Scholar 

  • Wagener, J. S., & Kupfer, O. (2012). Dornase alfa (Pulmozyme). Current Opinion in Pulmonary Medicine, 18(6), 609–614. doi:10.1097/MCP.0b013e328358d51f.

    Article  PubMed  Google Scholar 

  • Walters, J. A., Gibson, P. G., Wood-Baker, R., Hannay, M., & Walters, E. H. (2009). Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 1, CD001288. doi:10.1002/14651858.CD001288.pub3.

    Google Scholar 

  • Wang, F., He, X. Y., Baines, K. J., Gunawardhana, L. P., Simpson, J. L., Li, F., et al. (2011). Different inflammatory phenotypes in adults and children with acute asthma. The European Respiratory Journal, 38(3), 567–574. doi:10.1183/09031936.00170110.

    Article  CAS  PubMed  Google Scholar 

  • Wat, D., Gelder, C., Hibbitts, S., Cafferty, F., Bowler, I., Pierrepoint, M., et al. (2008). The role of respiratory viruses in cystic fibrosis. Journal of Cystic Fibrosis, 7(4), 320–328. doi:10.1016/j.jcf.2007.12.002.

    Google Scholar 

  • Wedzicha, J. A. (2002). Exacerbations: Etiology and pathophysiologic mechanisms. CHEST Journal, 121(5_suppl), 136S–141S.

    Article  Google Scholar 

  • Wedzicha, J. A., & Donaldson, G. C. (2012). Natural history of successive COPD exacerbations. Thorax, 67(11), 935–936. doi:10.1136/thoraxjnl-2012-202087.

    Article  PubMed  Google Scholar 

  • Weycker, D., Edelsberg, J., Oster, G., & Tino, G. (2005). Prevalence and economic burden of bronchiectasis. Clinical Pulmonary Medicine, 12(4), 205–209.

    Article  Google Scholar 

  • WHO. Asthma definition. http://www.who.int/respiratory/asthma/definition/en/

  • WHO. COPD definition. http://www.who.int/respiratory/copd/definition/en/index.html

  • Wong, C., Jayaram, L., Karalus, N., Eaton, T., Tong, C., Hockey, H., et al. (2012) Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): A randomised, double-blind, placebo-controlled trial. The Lancet, 380(9842), 660–667. doi:10.1016/s0140-6736(12)60953-2.

    Google Scholar 

  • Wurzel, D., Marchant, J. M., Yerkovich, S. T., Upham, J. W., Masters, I. B., & Chang, A. B. (2011). Short courses of antibiotics for children and adults with bronchiectasis. Cochrane Database of Systematic Reviews, 6, CD008695. doi:10.1002/14651858.CD008695.pub2.

    Google Scholar 

  • Yerkovich, S., Hales, B., Carroll, M., Burel, J., Towers, M., Smith, D., et al. (2012). Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation. BMC Pulmonary Medicine, 12(1), 37.

    Google Scholar 

  • Zirbes, J. M., & Milla, C. E. (2008). Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatric Pulmonology, 43(6), 607–610. doi:10.1002/ppul.20804.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Children’s Health Research, Children’s Health Queensland, 4101, Brisbane, QLD, Australia

    Vikas Goyal & Anne B. Chang

  2. Department of Respiratory and Sleep Medicine, Lady Cilento Children’s Hospital, 4101, Brisbane, QLD, Australia

    Anne B. Chang

Authors
  1. Vikas Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne B. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Vikas Goyal or Anne B. Chang .

Editor information

Editors and Affiliations

  1. Fraunhofer IME-TMP & JW Goethe University Frankfurt, Frankfurt am Main, Germany

    Michael J. Parnham

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing AG

About this entry

Cite this entry

Goyal, V., Chang, A.B. (2016). Acute Exacerbations of Airway Inflammation. In: Parnham, M.J. (eds) Compendium of Inflammatory Diseases. Springer, Basel. https://doi.org/10.1007/978-3-7643-8550-7_196

Download citation

Publish with us

Policies and ethics

Search

Navigation